These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15820276)

  • 21. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
    Champey J; Corruble E; Gottenberg JE; Buhl C; Meyer T; Caudmont C; Bergé E; Pellet J; Hardy P; Mariette X
    Arthritis Rheum; 2006 Jun; 55(3):451-7. PubMed ID: 16739213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving outcomes in depression: a focus on somatic symptoms.
    McIntyre RS; Konarski JZ; Mancini DA; Zurowski M; Giacobbe P; Soczynska JK; Kennedy SH
    J Psychosom Res; 2006 Mar; 60(3):279-82. PubMed ID: 16516660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.
    Fava M; Wiltse C; Walker D; Brecht S; Chen A; Perahia D
    J Affect Disord; 2009 Mar; 113(3):263-71. PubMed ID: 18625521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type-D personality and ankle brachial index as predictors of impaired quality of life and depressive symptoms in peripheral arterial disease.
    Aquarius AE; Denollet J; Hamming JF; Van Berge Henegouwen DP; De Vries J
    Arch Surg; 2007 Jul; 142(7):662-7. PubMed ID: 17638805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder.
    Lin CH; Yen YC; Chen MC; Chen CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():93-8. PubMed ID: 23989033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of adversity and perceived social support on the outcome of major depressive disorder in subjects with different levels of depressive symptoms.
    Leskelä U; Rytsälä H; Komulainen E; Melartin T; Sokero P; Lestelä-Mielonen P; Isometsä E
    Psychol Med; 2006 Jun; 36(6):779-88. PubMed ID: 16566849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
    Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and demographic factors associated with DSM-IV melancholic depression.
    Khan AY; Carrithers J; Preskorn SH; Lear R; Wisniewski SR; John Rush A; Stegman D; Kelley C; Kreiner K; Nierenberg AA; Fava M
    Ann Clin Psychiatry; 2006; 18(2):91-8. PubMed ID: 16754414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.
    Gore M; Brandenburg NA; Dukes E; Hoffman DL; Tai KS; Stacey B
    J Pain Symptom Manage; 2005 Oct; 30(4):374-85. PubMed ID: 16256902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
    Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
    Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity.
    Seemüller F; Riedel M; Wickelmaier F; Adli M; Mundt C; Marneros A; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Möller HJ; Henkel V
    J Affect Disord; 2008 Jun; 108(3):271-8. PubMed ID: 18164767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The integral inventory for depression, a new, self-rated clinimetric instrument for the emotional and painful dimensions in major depressive disorder.
    Dueñas H; Lara C; Walton RJ; Granger RE; Dossenbach M; Raskin J
    Int J Psychiatry Clin Pract; 2011 Sep; 15(3):171-9. PubMed ID: 22121927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dependency and self-criticism: relationship with major depressive disorder, severity of depression, and clinical presentation.
    Luyten P; Sabbe B; Blatt SJ; Meganck S; Jansen B; De Grave C; Maes F; Corveleyn J
    Depress Anxiety; 2007; 24(8):586-96. PubMed ID: 17143851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major depressive disorder: gender differences in symptoms, life quality, and sexual function.
    Lai CH
    J Clin Psychopharmacol; 2011 Feb; 31(1):39-44. PubMed ID: 21192141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double depression in adult psychiatric outpatients in Brazil: distinct from major depression?
    Holm-Denoma JM; Berlim MT; Fleck MP; Joiner TE
    Psychiatry Res; 2006 Nov; 144(2-3):191-6. PubMed ID: 16952402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of personality on objective and subjective social support among patients with major depressive disorder: a prospective study.
    Leskelä U; Melartin T; Rytsälä H; Jylhä P; Sokero P; Lestelä-Mielonen P; Isometsä E
    J Nerv Ment Dis; 2009 Oct; 197(10):728-35. PubMed ID: 19829200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in major depressive disorder: the role of pain and pain catastrophizing cognition.
    Chung KF; Tso KC; Yeung WF; Li WH
    Compr Psychiatry; 2012 May; 53(4):387-95. PubMed ID: 21684536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.